HB 1627

  • Arkansas House Bill
  • 2019 Regular Session
  • Introduced in House Feb 28, 2019
  • Passed House Mar 06, 2019
  • Passed Senate Mar 26, 2019
  • Signed by Governor Mar 29, 2019

To Amend The Law Regarding Information Exchange With Other Prescription Drug Monitoring Programs To Authorize Information Exchange With Federal Prescription Drug Monitoring Programs.

Votes


Actions


Mar 29, 2019

House

Notification that HB1627 is now Act 605

Mar 27, 2019

House

Correctly enrolled and ordered transmitted to the Governor's Office.

Mar 26, 2019

Senate

Read the third time and passed.

House

TO BE ENROLLED

House

Returned From the Senate as passed.

Senate

Returned to the House as passed.

Mar 20, 2019

Senate

Returned by the Committee, with the recommendation that it Do Pass

Mar 06, 2019

Senate

Read first time, rules suspended, read second time, referred to PUBLIC HEALTH, WELFARE AND LABOR COMMITTEE - SENATE

Senate

Received from the House.

House

Read the third time and passed and ordered transmitted to the Senate.

Mar 05, 2019

House

Returned by the Committee Do Pass

Feb 28, 2019

House

Filed

House

Read the first time, rules suspended, read the second time and referred to the Committee on PUBLIC HEALTH, WELFARE AND LABOR COMMITTEE- HOUSE

Bill Text

Bill Text Versions Format
HB 1627 PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Arkansas General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.